Basics Janux Therapeutics, Inc. IPO Date: June 11, 2021 Sector: Healthcare Industry: Biotech Market Cap: $1.44B Activated in VL: True Average Daily Range Avg Daily Range: $0.85 | 3.66% Avg Daily Range (30 D): $0.59 | 2.44% Avg Daily Range (90 D): $0.62 | 2.44% Institutional Daily Volume Avg Daily Volume: .34M Avg Daily Volume (30 D): .65M Avg Daily Volume (90 D): .73M Trade Size Avg Trade Size (Sh.): 66 Avg Trade Size (Sh.) (30 D): 63 Avg Trade Size (Sh.) (90 D): 65 Institutional Trades Total Inst.Trades: 1,372 Avg Inst. Trade: $2.2M Avg Inst. Trade (30 D): $1.59M Avg Inst. Trade (90 D): $1.74M Avg Inst. Trade Volume: .06M Avg Inst. Trades (Per Day): 2 Market Closing Trades Avg Closing Trade: $3.44M Avg Closing Trade (30 D): $2.23M Avg Closing Trade (90 D): $2.56M Avg Closing Volume: 93.29K     News Dec 4, 2024 @ 11:23 PM Why Janux Therapeutics Crushed the Market Today Source: Eric Volkman May 30, 2024 @ 3:01 PM The Latest Analyst Ratings For Janux Therapeutics Source: Benzinga Insights May 13, 2024 @ 1:00 PM Analyst Ratings For Janux Therapeutics Source: Benzinga Insights May 7, 2024 @ 12:15 PM Rhythm Pharmaceuticals, Inc. (RYTM) Reports Q1 Los... Source: Zacks Equity Research Apr 30, 2024 @ 12:50 PM Here's What Could Help Janux Therapeutics (JANX) M... Source: Zacks Equity Research Financials   TTM Q2 2025 Q1 2025 Basic EPS $-1.79 $-.55 $-.38 Diluted EPS $-1.79 $-.55 $-.38 Revenue $ .44M $ M $ M Gross Profit $ $ $ Net Income / Loss $ -105.64M $ -33.86M $ -23.51M Operating Income / Loss $ -144.88M $ -45.12M $ -34.9M Cost of Revenue $ $ $ Net Cash Flow $ 37.78M $ -21.3M $ -356.86M PE Ratio